Loading...
•
Dec 31, 2024
Post Q1 2025 Earnings Report
Post Holdings reported results for the first fiscal quarter ended December 31, 2024, with increases in net sales, operating profit, and net earnings.
Key Takeaways
Post Holdings reported a solid first fiscal quarter for 2025, with net sales increasing by 0.4% to $1,974.7 million, driven by acquisitions and growth in Foodservice. Operating profit rose by 2.3% to $214.1 million, and net earnings saw a significant 28.6% increase to $113.3 million. The company also raised its fiscal year 2025 Adjusted EBITDA outlook.
First quarter net sales reached $2.0 billion, a slight increase from the prior year.
Operating profit was $214.1 million, showing a 2.3% increase compared to the prior year period.
Net earnings increased by 28.6% to $113.3 million, and Adjusted EBITDA (non-GAAP) was $369.9 million.
Post Holdings raised its fiscal year 2025 Adjusted EBITDA (non-GAAP) outlook to $1,420-$1,460 million.
Post
Post
Post Revenue by Segment
Revenue by Segment
Post Consumer Brands Revenue
CapyFin.comWeetabix Revenue
CapyFin.comFoodservice Revenue
CapyFin.comRefrigerated Retail Revenue
CapyFin.com Forward Guidance
Post management raised its fiscal year 2025 Adjusted EBITDA outlook to $1,420-$1,460 million, with key assumptions related to avian influenza and capital expenditures.
Positive Outlook
- Post expects to recover any second fiscal quarter cost before pricing impact in the balance of the fiscal year.
- Post management's guidance range assumes recovery of lost egg supply over the remainder of the fiscal year.
- No additional avian influenza outbreaks are assumed within Post's controlled farms.
- Capital expenditures for fiscal year 2025 are projected to range between $380-$420 million.
- Significant investments are planned for network optimization and pet food safety and capacity within Post Consumer Brands.
Challenges Ahead
- The cost before pricing impact on the second fiscal quarter is estimated to be a headwind in the range of $30-$50 million due to avian influenza.
- The actual result for avian influenza impact could vary significantly from the estimated range due to volatility in egg market prices.
- The guidance does not provide a reconciliation of forward-looking Adjusted EBITDA to GAAP due to inherent difficulties in forecasting certain amounts.
- Adjustments for non-GAAP measures, such as income/expense on swaps, integration costs, and mark-to-market adjustments, could be significant.
- The prospective financial information is speculative and actual results may vary materially from the assumptions.
Revenue & Expenses
Visualization of income flow from segment revenue to net income